** Medical device maker Autonomix Medical's shares more than double to $21.07, highest since July ** Company says its radiofrequency ablation procedure reduced pain in patients with pancreatic cancer
** Says all patients who responded to the procedure went to zero opioid use at 4-6 weeks post procedure
** Radiofrequency ablation is a minimally invasive procedure that uses radio waves to destroy abnormal cells or tissue and treat pain
** As of last close, stock down 92.4% since its IPO in January
(Reporting by Christy Santhosh) ((mailto:Christy.Santhosh@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。